Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul;33(4):e13383.
doi: 10.1111/dth.13383. Epub 2020 Apr 24.

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Ömer Kutlu  1 , Ahmet Metin  1
Affiliations
Case Reports

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Ömer Kutlu et al. Dermatol Ther. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Comment in

  • Covid-19 and exacerbation of psoriasis.
    Ozaras R, Berk A, Ucar DH, Duman H, Kaya F, Mutlu H. Ozaras R, et al. Dermatol Ther. 2020 Jul;33(4):e13632. doi: 10.1111/dth.13632. Epub 2020 Jun 2. Dermatol Ther. 2020. PMID: 32436303 Free PMC article. No abstract available.

References

    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID‐19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2010;323(13):1239‐1242. 10.1001/jama.2020.2648. - DOI - PubMed
    1. Fu Y, Cheng Y, Wu Y. Understanding SARS‐CoV‐2‐mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020. 10.1007/s12250-020-00207-4. - DOI - PMC - PubMed
    1. Kalil AC. Treating COVID‐19 off‐label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. 2020. 10.1001/jama.2020.4742. - DOI - PubMed
    1. Velavan TP, Meyer CG. The COVID‐19 epidemic. Trop Med Int Health. 2020;25(3):278‐280. - PMC - PubMed
    1. Wolf R, Lo Schiavo A, Lombardi ML, De Angelis F, Ruocco V. The in vitro effect of hydroxychloroquine on skin morphology in psoriasis. Int J Dermatol. 1999;38(2):154‐157. - PubMed